MLPA-Based CNV Testing for BRCA1/BRCA2

Helsinki University Hospital area. The object of the procurement is an MLPA (Multiplex Ligation-dependent Probe Amplification) assay for the detection of copy number variations (CNVs) in BRCA1 and BRCA2 genes, including all reagents, controls, consumables, software, licences and other components re

quired for routine use of the assay and generation of reportable patient results. The procurement also includes any software, licences, user rights, technical support and related services required for operation of the assay, data analysis